Teva announces FDA approval for generic Saxenda
Teva Pharmaceuticals, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd., announced Aug. 28 that a generic version of Saxenda 1 (liraglutide injection) has received FDA…
Teva Pharmaceuticals, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd., announced Aug. 28 that a generic version of Saxenda 1 (liraglutide injection) has received FDA…